| Print
Saniona AB (SANION)
This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP
Company profile
Saniona AB researches and develops drugs for the treatment of diseases of the central nervous system, autoimmune diseases, metabolic diseases, and the treatment of pain. It develops a technology platform that enables the investigation of all types of ion channel drug targets. Its research is focused on GABAA receptors, nicotinic acetylcholine receptors, and potassium channels. The company product pipeline includes Tesomet, SAN711, Tesofensine, SAN903, and SAN2219. Geographically, it operates in USA, Sweden, Germany, Denmark, and United Kingdom, out of which it derives maximum revenue from USA.
Address
Forecast key dates
| Name | Key Date |
|---|---|
| Saniona AB Third Quarter Earnings Results for 2026 | 2026-11-27T08:00:00 |
| Saniona AB Second Quarter Earnings Results for 2026 | 2026-08-28T08:00:00 |
| Saniona AB Annual General Meeting for 2026 | 2026-05-28T16:30:00 |
| Saniona AB First Quarter Earnings Results for 2026 | 2026-05-28T08:00:00 |
| Saniona AB Annual Report for 2025 | 2026-04-30T00:00:00 |
| Saniona AB Fourth Quarter Earnings Results for 2025 | 2026-02-26T08:00:00 |
Previous key dates
| Name | Key Date |
|---|---|
| Saniona AB Third Quarter Earnings Results for 2025 | 2025-11-27T08:00:00 |
| Saniona AB Second Quarter Earnings Results for 2025 | 2025-08-28T08:00:00 |
| Saniona AB Annual General Meeting for 2025 | 2025-05-28T16:30:00 |
| Saniona AB First Quarter Earnings Results for 2025 | 2025-05-28T08:00:00 |
| Saniona AB Annual Report for 2024 | 2025-04-30T00:00:00 |
| Saniona AB Fourth Quarter Earnings Results for 2024 | 2025-02-27T08:00:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.